소세포성 폐암 (SCLC)

소개글

소세포성 폐암 (SCLC)에 대한 Harrison 발표용 정리본입니다.

목차

Epidemiology
Pathology
SCLC vs. NSCLC
Etiology
Clinical Manifestations
Paraneoplastic syndromes
Screening & Diagnosis
Staging
Staging Procedure (for SCLC)
Treatment
Prognosis
Reference

본문내용

Epidemiology
In 2007, United States
affected 114,760 males and 98,620 females
86% die within 5 years of diagnosis
leading cause of cancer death in both men and women
Incidence peaks between ages 55 and 65 years

Death rate
29% of all cancer deaths (31% in men, 26% in women)
more than breast, colon, and prostate cancer
decreasing in males, stable or still increasing in females

5-year survival rate : 15%
nearly doubled in the past 30 years, due to advances in combined-modality treatment with surgery, RTx, CTx.

참고 자료

Harrison’s principles of internal medicine, Fauci et al., McGraw-Hill, 2008, 17th.
Cecil medicine, Goldman & Ausiello, Elsevier, 2008, 23rd.
NCCN practice guideline in oncology.
Klos & O’Neil, Brain Metastases, The Neurologist, 2004;10(1): 31-46.
Victor Tse, Brain Metastasis, Emedicine, Nov 10, 2009.
(http://emedicine.medscape.com/article/1157902-overview)